Literature DB >> 28935487

Clinical prognostic factors of salivary adenoid cystic carcinoma: A single-center analysis of 61 patients.

Robert Cordesmeyer1, Henning Schliephake2, Philipp Kauffmann2, Markus Tröltzsch2, Rainer Laskawi3, Philipp Ströbel4, Felix Bremmer4.   

Abstract

PURPOSE: Adenoid cystic carcinomas are rare malignant tumors of the salivary glands. They are characterized by a high rate of local recurrence, late distant metastasis and a poor disease-free survival. In this study, we analyzed a series of 61 patients who were all treated at the University of Göttingen over a period of 21.0 years.
MATERIALS AND METHODS: In all 61 patients with salivary adenoid cystic carcinoma, clinical data, demographic data, risk factors, tumor location, tumor stage, status of surgical margin, surgical treatment, postoperative radiotherapy and follow-up interval were assessed.
RESULTS: The overall survival (OS) and the disease-free survival (DFS) of patients who underwent surgery and those who underwent combined surgery with radiotherapy showed no significant differences. Neither did the T-stage (T1/T2 vs. T3/T4) show significant differences in OS and DFS. Only the status of the surgical margin was significantly associated with a longer OS and a longer DFS.
CONCLUSION: The present results confirm that the radical surgical resection with clear tumor-free margins is the most important predictor for a longer survival. Adjuvant radiotherapy should be discussed from case to case, but should not be seen as an absolute prognostic factor for OS.
Copyright © 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenoid cystic carcinoma; Radiotherapy; Salivary gland; Surgery

Mesh:

Year:  2017        PMID: 28935487     DOI: 10.1016/j.jcms.2017.08.004

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  5 in total

1.  Evaluation of Multimodality Management of Adenoid Cystic Carcinoma of the Head and Neck.

Authors:  Amit Bahl; Naresh Kumar Panda; Arun Elangovan; Jaimanti Bakshi; Roshan Verma; Satyawati Mohindra; Rijuneeta Gupta; Arun Singh Oinam; Satinder Kaur; R K Vashishta; Sushmita Ghoshal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-07-07

2.  Clinical Prediction Nomograms to Assess Overall Survival and Disease-Specific Survival of Patients with Salivary Gland Adenoid Cystic Carcinoma.

Authors:  Hong-Shi Cai; Shuo-Jin Huang; Jian-Feng Liang; Yue Zhu; Jin-Song Hou
Journal:  Biomed Res Int       Date:  2022-08-29       Impact factor: 3.246

Review 3.  Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review.

Authors:  Giuditta Mannelli; Lara V Comini; Andrea Sacchetto; Roberto Santoro; Giuseppe Spinelli; Pierluigi Bonomo; Isacco Desideri; Paolo Bossi; Ester Orlandi; Giammarco Alderotti; Alessandro Franchi; Annarita Palomba; Albino Eccher; Daniele Marchioni; Riccardo Nocini; Cesare Piazza; Gabriele Molteni
Journal:  Head Neck       Date:  2022-04-20       Impact factor: 3.821

4.  Prognostic Factors and Survival in Adenoid Cystic Carcinoma of the Head and Neck: A Retrospective Clinical and Histopathological Analysis of Patients Seen at a Cancer Center.

Authors:  Everton Freitas de Morais; Leorik Pereira da Silva; Deborah Gondim Lambert Moreira; Rodrigo Porpino Mafra; Larissa Santos Amaral Rolim; Edilmar de Moura Santos; Lélia Batista de Souza; Roseana de Almeida Freitas
Journal:  Head Neck Pathol       Date:  2020-08-10

5.  Pretherapeutic Serum Albumin as an Outcome Prognosticator in Head and Neck Adenoid-Cystic Carcinoma.

Authors:  Marlene Friedl; Stefan Stoiber; Faris F Brkic; Lorenz Kadletz-Wanke
Journal:  Biomedicines       Date:  2022-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.